|
Volumn 147, Issue , 1998, Pages 83-94
|
Phase I/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal cancer hepatic metastases.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
MELPHALAN;
MITOMYCIN;
ANIMAL;
COLORECTAL TUMOR;
HUMAN;
LIVER TUMOR;
METASTASIS;
PATHOLOGY;
PERFUSION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
RAT;
REVIEW;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
COLORECTAL NEOPLASMS;
HUMANS;
LIVER NEOPLASMS;
LIVER NEOPLASMS, EXPERIMENTAL;
MELPHALAN;
MITOMYCIN;
PERFUSION;
RATS;
|
EID: 0031626389
PISSN: 00800015
EISSN: None
Source Type: Journal
DOI: 10.1007/978-3-642-80460-1_9 Document Type: Review |
Times cited : (27)
|
References (34)
|